Khwab Sanghvi
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Employing RNA editing to engineer personalized tumor-specific neoantigens (editopes).
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
Engineering editopes through programmable RNA editing toward tumor neoantigen generation.
Journal: The EMBO journal
Published: November 24, 2025
Type I interferon drives T cell responses to amyloid beta in the central nervous system.
Journal: Nature communications
Published: October 23, 2024
T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells.
Journal: Neuro-oncology advances
Published: October 05, 2022
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors.
Journal: Cancer cell
Published: May 10, 2022
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes.
Journal: Neuro-oncology advances
Published: November 05, 2021
T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 23, 2021
A vaccine targeting mutant IDH1 in newly diagnosed glioma.
Journal: Nature
Published: October 19, 2020
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas.
Journal: Nature cancer
Published: July 15, 2020
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Journal: Nature communications
Published: November 25, 2019
TCR validation toward gene therapy for cancer.
Journal: Methods in enzymology
Published: November 16, 2019
Last Updated: 09/26/2026